Skip to main content
Clinical Trials/IRCT20171212037850N1
IRCT20171212037850N1
Completed
Phase 3

A comparative study on the efficacy of levetiracetam and amitriptyline in childhood migraine; An open-label randomized controlled trial

Esfahan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All of children with migraine headache with or without aura, at least two attack per week or four attack per month, so that the attacks cause them to consume the analgesics or interfere with everyday activities

Exclusion Criteria

  • Complicated migraine
  • Not having the ability to record data related to the number, duration, and severity of headaches
  • Use of other prophylactic drugs other than Levetiracetam and Amitriptyline
  • Severe psychiatric problems like depression and ADHD
  • Hypersensitivity to tricyclic anti depressants drugs
  • Taking analgesic more than 4 times a week for migraine headache

Outcomes

Primary Outcomes

Not specified

Similar Trials